These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 830579

  • 1. Serum lipids, insulin, and glucagon after portacaval shunt in cirrhosis.
    Shurberg JL, Resnick RH, Koff RS, Ros E, Baum RA, Pallotta JA.
    Gastroenterology; 1977 Feb; 72(2):301-4. PubMed ID: 830579
    [Abstract] [Full Text] [Related]

  • 2. Hyperglucagonemia in cirrhosis: altered secretion and sensitivity to glucagon.
    Sherwin RS, Fisher M, Bessoff J, Snyder N, Hendler R, Conn HO, Felig P.
    Gastroenterology; 1978 Jun; 74(6):1224-8. PubMed ID: 648812
    [Abstract] [Full Text] [Related]

  • 3. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A, Contini S, Bonora E, Marni A, Colotto G, Capocasale E, Butturini U.
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [Abstract] [Full Text] [Related]

  • 13. Effect of portasystemic venous shunt surgery on hyperglucagonaemia in cirrhosis: paired studies of pre- and post-shunted subjects.
    Dudley FJ, Alford FP, Chisholm DJ, Findlay DM.
    Gut; 1979 Oct; 20(10):817-24. PubMed ID: 533693
    [Abstract] [Full Text] [Related]

  • 14. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P, Fujita Y, Unger RH.
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of soluble fiber intake in lipid and glucose levels in healthy subjects: a randomized clinical trial.
    Aller R, de Luis DA, Izaola O, La Calle F, del Olmo L, Fernandez L, Arranz T, Hernandez JM.
    Diabetes Res Clin Pract; 2004 Jul; 65(1):7-11. PubMed ID: 15163472
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC, Chapman C, Lovegrove JA, Isherwood SG, Morgan LM, Wright JW, Williams CM.
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [Abstract] [Full Text] [Related]

  • 19. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 20. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
    Kabadi UM, Kabadi MU, Premachandra BN.
    Am J Gastroenterol; 1991 Oct 15; 86(10):1504-7. PubMed ID: 1928046
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.